Clinical Trials Industry News More
-
Researchers Use Golden Nanotubes For Imaging Agent To Detect Tumor Cells, Map Sentinel Lymph Node
8/31/2009
Biomedical researchers at the University of Arkansas for Medical Sciences in Little Rock have developed a special contrast-imaging agent that is capable of molecular mapping of lymphatic endothelial cells and detecting cancer metastasis in sentinel lymph nodes.
-
Thermo Fisher Scientific Introduces Stainless Steel Interior Models For Class II, Type A2 Biological Safety Cabinets
8/19/2009
Thermo Fisher Scientific Inc., the world leader in serving science, has introduced a one-piece stainless steel interior option for the Thermo Scientific 1300 Series A2 Biological Safety Cabinets.
-
Dual Devices By Pitt Researchers Harness Carbon Nanomaterials For Enhanced Drug Delivery Systems, Oxygen Sensors
8/18/2009
Two nanoscale devices recently reported by University of Pittsburgh researchers in two separate journals harness the potential of carbon nanomaterials to enhance technologies for drug or imaging agent delivery and energy storage systems, in one case, and, in the other, bolster the sensitivity of oxygen sensors essential in confined settings, from mines to spacecrafts.
-
CryoStim™ Cancer Treatment To Begin FDA Clinical Trials September 1, 2009
8/16/2009
Immunovative Therapies Ltd. has announced that its CryoStim™ experimental product has been cleared by the FDA to begin human clinical trials. Immunovative Therapies, Ltd. experimental products are based upon “Mirror Effect™” technology (patents issued and pending) which is designed to provide the same anti-tumor effect that has been proven to be curative in allogeneic bone marrow transplant (BMT) procedures without the lethal toxicity or need for a matched donor.
-
Grant Instruments Expands Data Logging Range With Acquisition Of Assets And IP Of California-Based Company Accsense
8/11/2009
Grant Instruments, a world-renowned supplier and manufacturer of own-brand scientific, life sciences and data acquisition products, has acquired the assets and intellectual property of California-based Accsense, Inc., a company that designs remote monitoring systems using self healing wireless mesh network technology.
-
Biota Holdings Announces Successful Phase III Asian Clinical Trials Of Its Second Generation Flu Treatment
8/11/2009
Biota Holdings Limited (ASX: BTA) today announced successful results from the Asian Phase III clinical trials of CS-8958, its second generation influenza treatment.
-
Position Paper Highlights Advancements In Balance Enclosure Technology
8/3/2009
Labconco Corporation offers an 8-page white paper titled, “Advances in Balance Enclosure Technology Bring Safety Enhancements to the Pharmaceutical Industry.”
-
M2S Announces New Clinical Trial Product, iMAS, A Medical Image Collect And Hold Solution
7/30/2009
M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, today announced that it has launched a new product to collect and hold medical images in clinical trials, called iMAS (Image Management Archive System).
-
Transformational Transaction Establishes Agilent’s Position As A Leading Provider Of Analytical Instrumentation To The Applied And Life Sciences Markets
7/29/2009
Agilent Technologies Inc. and Varian Inc. recently announced that they have signed a definitive agreement for the acquisition by Agilent of Varian, a leading worldwide supplier of scientific instrumentation and associated consumables for life science and applied market applications.
-
Generex Publishes Results From Pre-Clinical Studies On Immunotherapeutic Vaccine For HPV-Induced Cervical Cancer
7/23/2009
Generex Biotechnology Corporation announced today publication of studies demonstrating the anti-cancer activity of a novel Ii-Key/HPV immunotherapeutic vaccine.
This website uses cookies to ensure you get the best experience on our website. Learn more